LUPINPharmaceuticals
Lupin Ltd — Quarterly Results & Earnings
₹2313.90
-0.66%
Profit Growth YoY73.34%Latest quarter
Sales Growth YoY24.23%Latest quarter
Sales CAGR 5Y8.11%5 year compound
Profit CAGR 5Y54.88%5 year compound
📋
Quarterly Performance
YoY Profit Growth+73.34%
🔥 Exceptional growth
YoY Sales Growth+24.23%
🔥 Exceptional growth
OPM 5Y Average
14.94%Operating profit margin
EPS Growth 5Y
54.69%Interest Coverage
16.17Higher = safer debt servicing
ROE
20.62%ROCE
21.30%💡
Growth Analysis
Lupin Ltd reported YoY profit growth of 73.34% and revenue growth of 24.23% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 8.11% and profits at 54.88% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Lupin Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.